Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Kindred Biosciences.

    Client Virtual Booth

    KINDRED BIOSCIENCES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Kindred Biosciences
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kindredbio.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/kindredbio
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart

    Details:

    Under the terms of the agreement, KindredBio will provide manufacturing services for the manufacture of Vaxart 's oral vaccine candidate for COVID-19 from its state-of-the-art biological development and cGMP production facility in Burlingame, CA.


    Lead Product(s): COVID-19 vaccine

    Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

    Highest Development Status: PreclinicalProduct Type: Vaccine

    Partner/Sponsor/Collaborator: Vaxart

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement May 20, 2020

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Kindred Biosciences Announces Mirataz® (mirtazapine transdermal ointment) Transaction

    Details:

    The company has entered into a transaction for the sale of Mirataz® to Dechra Pharmaceuticals PLC.


    Lead Product(s): Mirtazapine

    Therapeutic Area: Nutrition and Weight Loss Product Name: Undisclosed

    Highest Development Status: ApprovedProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Dechra Pharmaceuticals Manufacturing

    Deal Size: Undisclosed Upfront Cash: $43.0 million

    Deal Type: Divestment March 16, 2020

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search